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Keloid Clues
To study the IL-6 signal pathway in keloid 
pathogenesis, Ghazizadeh and co-work-
ers subjected primary cultures of keloid 
fibroblasts (KFs) and surrounding non-
lesional fibroblasts (NFs) to induction or 
inhibition of IL-6 or its receptor, IL-6R. They 
also examined the effects on extracellular 
matrix gene expression as well as the lev-
els of gp130, the IL-6 signal transducer pro-
tein, and several downstream targets in IL-6 
signaling. IL-6 secretion was significantly 
higher in KFs than in NFs. IL-6 signaling 
appears to hold a major role in keloid pathogenesis. This provides clues for the devel-
opment of IL-6 receptor-blocking strategies for therapy or prophylaxis of keloid scar. 
See page 98
Acoustic Magnifying Glass
Rallan and colleagues adapted and refined 
three-dimensional high-resolution ultra-
sound-reflex transmission imaging (HRU-
RTI) with randomly selected patients who 
had been referred from primary care with 
suspected melanoma. They quantified the 
acoustic differences among malignant 
melanoma (n = 25), seborrheic kerato-
sis (n = 24), and other benign pigmented 
nevi (n = 38). Using perilesional skin as a 
control, they found significant quantitative 
differences between benign and malignant 
pigmented lesions; this could reduce the 
biopsy of benign tumors by 65% without 
missing melanoma. See page 189
Antiapoptotic GVHD Target Cells
Target-cell apoptosis in murine graft-versus-host 
disease (GVHD) preferentially involves sub-popu-
lations of basal cells that, among other attributes, 
reside at tips of lingual rete ridge-like prominences, 
express cytokeratin 15 (K15) protein, and express 
the proapoptotic protein Bax early in disease pro-
gression. Zhan and colleagues showed that K15+ 
murine basal cells express lower mRNA levels 
of Bax than do K15– basal cells, and that there is 
a trend toward the preferential expression of genes associated with protection from 
apoptosis. It appears possible to distinguish the genes that regulate apoptotic vulner-
ability in GVHD. See page 106 
Vicious AD Circle
Jakasa and colleagues assessed 
the barrier function of atopic 
dermatitis (AD) patients’ unin-
volved skin. Using various 
molecular weights of polyethyl-
ene glycols (PEGs) to penetrate 
the skin in vivo, they showed 
increased diffusion coefficients 
for all PEGs in AD patients as 
compared with control sub-
jects. This suggests that skin 
barrier function is altered even 
in skin that is visibly unaffect-
ed by AD. AD patients might 
have a higher susceptibility 
for inflammation of the unin-
volved skin, which in turn will 
increase permeability, resulting 
in a vicious circle. New drug 
compounds with larger mol-
ecules might square that circle. 
See page 129 
HPV Hangs Out in 
Skin
To determine whether cuta-
neous human papillomavi-
rus (HPV) persists over time, 
Hazard et al. took forehead 
swab samples 6.3 years apart 
(mean) from 42 healthy indi-
viduals and 31 renal transplant 
recipients (RTRs). The preva-
lence of HPV in healthy sub-
jects was 69% at enrollment 
and 71% at follow-up. Among 
RTRs, 71% were positive for 
HPV at enrollment, and 90% 
at follow-up. In total, HPV was 
detected in 44 of the samples 
collected at baseline, and the 
same virus was found at fol-
low-up in 43%. Persistence 
was not significantly associat-
ed with immunosuppression, 
age, sex, history of warts, or 
genus of HPV. See page 116
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